Capcom's half-year report landed on October 27, and the headline number is not the one on the press release. Yes, net sales for April to September 2026 were ¥120.9 billion, up 49% on the same period last year, and operating profit rose 54.5% to ¥60.8 billion. The more interesting figure is buried in the results explanation: of the 36.86 million games Capcom sold in six months, 32.18 million were catalog titles, games that are at least a year old. New releases made up 12.7% of the pile. Capcom is, by volume, a company that sells you its back catalog, and the new games exist in large part to keep that catalog moving.
That is not a criticism. It is the plan, stated in Capcom's own words: "latest titles across series drive growth in catalog sales, creating a virtuous cycle that boosts earnings." Resident Evil Requiem, released in February, has now passed 8.51 million lifetime units, with 1.59 million of those in the half-year. But look at what sat above it in Capcom's own ranking for the period. Resident Evil 4's remake, from 2023, shifted 3.54 million units in six months and now stands at 17.15 million. Resident Evil 2 added 2.06 million to reach 20.38 million. Devil May Cry 5 moved 1.83 million. Resident Evil 3, 7 and Village each sold well over a million. Capcom credits "pricing initiatives", which is investor language for the discounts you keep seeing on Steam and the PlayStation Store.
The new games did fine too
The two 2026 releases both show up near the top. Pragmata, out in April, reached 2.73 million units. Onimusha: Way of the Sword, released on September 4 as the first new entry in that series for 20 years, had passed 1.7 million by the end of the month, with Capcom noting two awards at Gamescom and a Metascore of 85, the same as Pragmata's. Requiem sits at 89. None of these is a Monster Hunter Wilds-scale launch, and Capcom does not pretend otherwise; the report leans on breadth rather than one blockbuster, and the half-year unit total compares with 23.85 million a year earlier.
Where the games sell is the other story. Digital accounted for 92.4% of units, split 57.1% on PC and 35.3% on consoles, leaving physical at 7.6%, or about 2.8 million discs and cartridges. The full-year plan goes further: 65 million units with physical down to 4.6%. Push Square, reading the same deck, summarised it as physical copies barely registering, and that is fair, although the Switch 2 ports of Resident Evil 2, 3 and 4 in October and Monster Hunter Wilds on December 4 will test whether Nintendo's audience nudges the boxed share back up before March. Overseas buyers took 89.4% of units; Japan, 10.6%.
What it means for players
If you have wondered why Capcom's remakes and 2019-era games never seem to leave the sale charts, this report is the answer. The company has every incentive to keep Resident Evil 2, 4 and Devil May Cry 5 cheap and visible, because each new series entry sends a fresh wave of players back through them. It also explains the steady drip of ports: the Switch 2 versions and the Dark Arisen edition of Dragon's Dogma 2 are catalog revenue with a new sticker. The series totals Capcom now quotes are 218 million for Resident Evil, 132 million for Monster Hunter and 60 million for Street Fighter.
As for what is next, Capcom left its full-year forecast unchanged at ¥210 billion in sales and ¥83 billion in operating profit, and its release list is the roadmap: Monster Hunter Wilds on Switch 2 on December 4, then Mega Man: Dual Override in spring 2027, the Monster Hunter Wilds: Ascendance expansion and Resident Evil Veronica, both dated only as 2027. No new title announcements came with the results, and the Nintendo Life and Push Square write-ups note nothing beyond the deck. The next data point is the third-quarter report early in 2027, which will show whether a Switch 2 Monster Hunter does for catalog sales what Requiem did this year.
Reporting notes